Walking Fish Therapeutics Overview
- Year Founded
-
2019
- Status
-
Out of Business
- Employees
-
22
- Latest Deal Type
-
Out of Business
Walking Fish Therapeutics General Information
Description
Developer of cell-based therapeutics designed to treat serious diseases. The company's therapeutics harness the power of locally acting proteins using B cell factories for oncology, regenerative medicine, autoimmune disease, and recombinant antibody production, enabling doctors to concentrate on oncology and regenerative therapies.
Contact Information
Website
www.walkingfishtx.comCorporate Office
- 450 East Jamie Court
- Suite 300
- South San Francisco, CA 94080
- United States
Corporate Office
- 450 East Jamie Court
- Suite 300
- South San Francisco, CA 94080
- United States
Walking Fish Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 04-May-2024 | Completed | Out of Business | |||
| 2. Early Stage VC | 16-Feb-2022 | Completed | Generating Revenue | |||
| 1. Early Stage VC (Series A) | 13-Sep-2021 | $73M | $73M | Completed | Generating Revenue |
Walking Fish Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-3 | ||||||||
| Series A-2 | ||||||||
| Series A-1 | 41,798,421 | $0.000100 | 8% | $0.93 | $0.93 | 1x | $0.93 | 41.65% |
Walking Fish Therapeutics Comparisons
Industry
Financing
Details
Walking Fish Therapeutics Competitors (2)
One of Walking Fish Therapeutics’s 2 competitors is Actitrexx, a Venture Capital-Backed company based in Mainz, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Actitrexx | Venture Capital-Backed | Mainz, Germany | ||||
| TScan Therapeutics | Formerly VC-backed | Waltham, MA |
Walking Fish Therapeutics Patents
Walking Fish Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4680727-A2 | Methods for in vivo editing of b cells | Inactive | 17-Mar-2023 | ||
| WO-2024196669-A2 | Methods for in vivo editing of b cells | Inactive | 17-Mar-2023 | ||
| WO-2024196669-A3 | Methods for in vivo editing of b cells | Inactive | 17-Mar-2023 | ||
| WO-2024151683-A2 | Human b cell engineered to express iga and igm antibodies for therapeutic use | Inactive | 09-Jan-2023 | ||
| WO-2024151683-A3 | Human b cell engineered to express iga and igm antibodies for therapeutic use | Inactive | 09-Jan-2023 | C07K16/11 |
Walking Fish Therapeutics Signals
Walking Fish Therapeutics FAQs
-
When was Walking Fish Therapeutics founded?
Walking Fish Therapeutics was founded in 2019.
-
Where is Walking Fish Therapeutics headquartered?
Walking Fish Therapeutics is headquartered in South San Francisco, CA.
-
What is the size of Walking Fish Therapeutics?
Walking Fish Therapeutics has 22 total employees.
-
What industry is Walking Fish Therapeutics in?
Walking Fish Therapeutics’s primary industry is Biotechnology.
-
Is Walking Fish Therapeutics a private or public company?
Walking Fish Therapeutics is a Private company.
-
What is Walking Fish Therapeutics’s current revenue?
The current revenue for Walking Fish Therapeutics is .
-
How much funding has Walking Fish Therapeutics raised over time?
Walking Fish Therapeutics has raised $85.7M.
-
Who are Walking Fish Therapeutics’s competitors?
Actitrexx and TScan Therapeutics are competitors of Walking Fish Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process